系统评价氢化可的松持续静脉泵注给药与静脉 滴注给药对脓毒症休克患者近期预后的影响. (Chinese)

Systematic Review on Effects of Continuous Intravenous Pump Administration and Intravenous Drip Administration of Hydrocortisone on Short-Term Prognosis in Patients with Septic Shock. (English)

OBJECTIVE: To systematically evaluate the effects of continuous intravenous pump administration and intravenous drip administration of hydrocortisone on short-term prognosis in patients with septic shock. METHODS: CNKI, Wanfang Data, VIP, CBM, PubMed, Embase, MEDLINE, Web of Science and the Cochrane Library databases were retrieved to collect randomized controlled trials of continuous intravenous pump administration and intravenous drip administration of hydrocortisone in the treatment of patients with septic shock. The retrieval time was from the establishment of the database to Apr. 2022. After literature screening and effective data extraction, RevMan 5. 3 software was used for Meta-analysis. RESULTS: Totally 15 articles were enrolled, including 1 628 patients, 809 cases of whom received intravenous infusion and 819 cases of whom received continuous intravenous pump administration. Results of Meta-analysis showed that the 28-day mortality rate of continuous intravenous pump administration of hydrocortisone (26. 65%, 182/683 ) was lower than that of intravenous drip administration (30. 65%, 206/672), yet the difference was not statistically significant (RR = 0. 86,95%CI = 0. 73-1. 02,P = 0. 08). Compared with intravenous drip administration, continuous intravenous pump administration could significantly improve the serum lactate clearance (MD = 1. 39,95%CI = 0. 90-1. 87,P<0. 000 01), shorten the duration of shock (MD = -0. 18, 95%CI = -0. 26--0. 11, P<0. 000 01), length of stay in intensive care unit (ICU) (MD = -1. 54, 95%CI = -1. 82--1. 26, P < 0. 000 01), and total length of stay (MD = - 0. 94, 95% CI = - 1. 31-- 0. 57, P < 0. 000 01), the differences were statistically significant. CONCLUSIONS: Compared with multiple intravenous drip administration of hydrocortisone, continuous intravenous pump administration can not significantly reduce the 28-day mortality of patients with septic shock, yet can significantly reduce the level of blood lactic acid, reverse the duration of shock as soon as possible, shorten the length of stay in ICU and total length of stay. [ABSTRACT FROM AUTHOR]

目的: 系统评价氢化可的松静脉泵注给药与静脉滴注给药对脓毒症休克患者近期预后的影响。方法: 检索中国知网、万 方数据库、维普数据库、中国生物医学数据库、PubMed、Embase、MEDLINE、Web of Science 和 the Cochrane Library 等数据库自建库 至 2022 年 4 月关于氢化可的松持续静脉泵注与静脉滴注治疗脓毒症休克的随机对照试验, 进行文献筛选和提取有效数据后, 采 用 RevMan 5. 3 软件进行 Meta 分析。结果: 纳入 15 篇文献, 共 1 628 例患者, 其中 809 例采用静脉滴注给药, 819 例采用持续静脉 泵注给药。Meta 分析结果显示, 氢化可的松持续静脉泵注给药的 28 d 病死率 (26. 65%, 182 / 683) 低于静脉滴注给药 (30. 65%, 206 / 672), 但差异无统计学意义(RR= 0. 86, 95%CI = 0. 73~ 1. 02, P= 0. 08); 与静脉滴注给药比较, 持续静脉泵注给药能显著提高 患者的血清乳酸清除率 (MD= 1. 39, 95%CI = 0. 90~ 1. 87, P<0. 000 01), 缩短休克持续时间 (MD = -0. 18, 95%CI = -0. 26 ~ -0. 11, P<0. 000 01)、入住重症监护室 (ICU) 时间 (MD= -1. 54, 95%CI = -1. 82~ -1. 26, P<0. 000 01) 和总住院时间 (MD= -0. 94, 95%CI = -1. 31~ -0. 57, P<0. 000 01), 差异均有统计学意义。结论: 与氢化可的松多次静脉滴注给药方式相比, 持续静脉泵注给药尽管不能 显著降低脓毒症休克患者的 28 d 病死率, 但可显著降低患者血乳酸水平, 尽快扭转休克持续时间, 缩短入住 ICU 时间和总住院时间。 [ABSTRACT FROM AUTHOR]

Copyright of Evaluation & Analysis of Drug-Use in Hospitals of China is the property of Evaluation & Analysis of Drug-Use in Hospitals of China Editorial Board and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)